DCF — GARFIELD MEDICAL CENTER
Enterprise Value: $-161.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-161.8M
Enterprise Value
$-54.1M
PV of Cash Flows
$-107.7M
PV of Terminal Value
$-173.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $188.4M | $-8.5M | -4.0% | $-16.5M | $-15.0M |
| Year 2 | $194.1M | $-6.8M | -3.0% | $-15.0M | $-12.4M |
| Year 3 | $199.9M | $-5.0M | -2.0% | $-13.5M | $-10.1M |
| Year 4 | $205.9M | $-4.1M | -2.0% | $-12.8M | $-8.8M |
| Year 5 | $212.1M | $-3.7M | -2.0% | $-12.7M | $-7.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-161.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$183.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999863351273
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5